10x Genomics TXG

85.71 1.60 1.90% as of 25 Sep
Market cap
$11.1B
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cash and Short Term Investments
523.41 393.40 388.70 432.62 588.48 680.17 424.17 65.08 48.00
Receivables
82.49 88.47 114.83 104.21 85.25 51.21 33.37 28.09 13.00
Inventory
56.34 83.11 73.71 81.63 59.97 29.96 15.27 8.57 5.00
Total current assets
684.45 584.39 596.02 635.04 747.59 774.37 480.84 106.24 68.00
Property, Plant, Equpment (Net)
226.71 252.65 279.57 289.33 169.49 72.84 48.82 11.13 7.00
Goodwill and Intangible Assets (Total)
66.84 20.18 21.13 27.37 29.91 22.35 22.00 — 0.00
Long-term assets (Other)
2.91 4.13 3.06 7.37 10.92 12.80 76.26 6.95 1.00
Total non-current assets
356.91 334.25 369.12 393.95 271.24 154.98 125.08 18.07 —
Total Assets
1,041.37 918.64 965.14 1,028.98 1,018.83 929.34 605.92 124.31 0.00
Accounts Payable
12.73 12.91 15.74 21.60 17.35 4.71 13.03 8.79 5.00
Accrued Expenses
82.47 74.78 86.75 92.45 82.54 103.01 36.84 16.99 —
Current Part of Debt
— — — 9.00 5.00 6.00 9.88 4.19 4.00
Current Part of Capital Lease
— — — — — — — — 0.00
Current Part of Taxes to Pay
— — — — — — — — 0.00
Current Revenue (Deferred)
23.90 20.66 13.15 7.87 5.34 4.47 3.30 2.40 —
Other current liabilities
23.36 — — 96.00 83.00 99.00 39.00 19.00 12.00
Total current liabilities
153.45 117.63 127.16 130.96 110.36 118.13 63.05 32.36 22.00
Long Term Debt (Total)
— — — 86.00 77.00 57.00 19.84 25.49 165.00
Non-current Revenue (Deferred)
10.50 12.51 8.81 3.17 — — 16.12 4.43 0.00
Minority Interests
— — — — — — — — 0.00
Non-current Liabilities (Other)
7.71 5.03 4.28 2.98 14.05 15.10 86.83 38.77 1.00
Total non-current liabilities
91.59 90.87 96.94 92.28 90.90 72.14 122.79 68.69 —
Total liabilities
245.04 208.50 224.10 223.24 201.26 190.27 185.84 101.05 0.00
Additional Paid In Capital
2,306.69 2,177.67 2,025.89 1,839.40 1,680.87 1,544.22 682.49 11.17 0.00
Preferred Stock (Total)
— — — — — — — 243.24 0.00
Common Stock (Net)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Retained Earnings
(1,510.59) (1,467.05) (1,284.42) (1,029.32) (863.32) (805.10) (262.37) (231.12) (119.00)
Treasury Stock
— — — — — — — — 0.00
Shareholders Equity (Other)
— — — — — — — — 0.00
Common Equity (Total)
796.33 710.13 741.04 805.74 817.57 739.07 420.08 (219.99) (113.00)
Shareholders Equity (Total)
796.33 710.13 741.04 805.74 817.57 739.07 420.08 23.26 0.00
Shareholders Equity and Liabilities (Total)
1,041.37 918.64 965.14 1,028.98 1,018.83 929.34 605.92 124.31 0.00
Shares (Common)
127.69 122.29 119.10 115.20 112.52 108.49 96.24 14.55 —
Shares (Preferred)
— — — — — — — 67.70 —
Shareholders Equity (Tangible)
729.49 689.95 719.92 778.37 787.66 716.72 420.08 23.26 —
Net Debt
(523.41) (393.40) (388.69) (337.62) (506.47) (617.17) (394.45) (35.40) 121.00
Total Debt
— — — 95.00 82.00 63.00 29.72 29.68 169.00

Fold the line items

In millions of $ except per-share values · columns are period end dates